GSK3B and mantle cell lymphoma: Defects in WCP were initially reported by our group [18], in which we employed immunohistochemistry and identified 33 (52%) of 64 MCL tumors showing constitutive WCP activation, as evidenced by the nuclear localization of β-catenin and the expression of the p-GSK3β.